Access Bio
Even the most sophisticated, cutting-edge medical diagnostics aren’t of value unless we can get them to those who need them most. At Access Bio, we believe every life is precious, and every human on earth deserves the opportunity to live a healthy life, free from the threat of infectious diseases. Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. Based on the greatest needs and the potential to do the most good, we work with partners across the world, including the Bill and Melinda Gates Foundation, the World Health Organization, UNICEF, and many others.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
A Trusted Partner In Global Health
Access Bio’s mission is to improve the lives and well-being of people around the world. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized the highest quality products to battle malaria and other serious diseases.
We are a trusted partner to international public health agencies and organizations, including the World Health Organization, the Bill and Melinda Gates Foundation, UNICEF, and many others.
Our Vision and Strategy
A Sustainable Business Based on Innovation, Value, and Global Good
Vision
Heading Global pioneer in invitro diagnostic technologies
Mission
Promote health and well-being of mankind via accurate diagnosis of diseases
Strategy
Reinforce Market Presence and Diversify Markets
Reinforce market footing in malaria diagnosis; launch new diagnostic products including tests for COVID-19, G6PD deficiency, dengue fever, influenza, and strep
Strengthen Quality Control and Customer Relationships
Maintain stringent quality control; strengthen relationships with customers including international agencies, non-profit organizations, and retailers.
Develop Value-Added Products
Build a portfolio of value-added products based on cutting-edge technologies in in vitro diagnostics.
Enhance Sustainability of Profits
Reduce costs via product diversification, economies of scale, and production automation.
CEO Message
Each and Every Life is Precious
A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe.
Since our inception in 2002, we have built a strong presence in the global market for the diagnostic testing of malaria and instilled hope for a healthy life among those suffering from this deadly disease.
Our Work Has Just Begun
As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance.
With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders.